Visual and Refractive Outcomes After Bilateral Implantation of a New Toric Intraocular Lens

Maya C Shammas,1 H John Shammas1,2 1The Department of Ophthalmology, The Shammas Eye Medical Center, Lynwood, CA, USA; 2The Department of Ophthalmology, University of Southern California, The Keck School of Medicine, Los Angeles, CA, USACorrespondence: Maya C Shammas, The Department of Ophthalmology, The Shammas Eye Medical Center, 3510 Martin Luther King Jr. Blvd, Lynwood, CA, 90262, USA, Tel +1 310 638 9391, Email [email protected]: To evaluate the clinical outcomes of a new FDA approved toric aspheric hydrophobic acrylic intraocular lens.Patients and Methods: This is a single surgeon, single-arm, on-label, non-randomized, prospective observational study. Thirty patients underwent bilateral cataract surgery (60 eyes) with placement of a Clareon™ Toric IOL in each eye. The Barrett Universal II formula and Barrett toric calculator were used to determine the IOL power and toric axis. Endpoints included binocular and monocular best corrected distance visual acuity (BCDVA), binocular and monocular best uncorrected distance visual acuity (UCDVA), binocular uncorrected intermediate visual acuity (UCIVA), manifest refraction and patient Satisfaction Survey (IOLSAT) results over a 3 month follow-up.Results: The postoperative mean LogMAR visual acuity for binocular BCDVA and UCDVA were each 0.01± 0.05. The monocular BCDVA and UCDVA were 0.04± 0.06 and 0.08± 0.08 respectively. The mean refractive cylinder improved from 1.87± 1.12D to 0.43± 0.25D with 78.3% within 0.50D. The mean refractive spherical equivalent (MRSE) was 0.008 ± 0.30 D (range − 0.75 to +0.63, 93.3% results within ± 0.5D). Patient surveys showed 96.7% gained distance spectacle independence and 96.7% would recommend this lens to friends or family members.Conclusion: The Clareon Monofocal Toric IOL is effective in astigmatism correction and significantly improved uncorrected distance visual acuity. High spectacle independence for distance vision and high overall satisfaction were achieved.Keywords: toric, intraocular lens, IOL, cataract, astigmatism

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2024-12-01
Primary Topic
Enzyme Structure and Function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Visual and Refractive Outcomes After Bilateral Implantation of a New Toric Intraocular Lens

SHILAP Revista de lepidopterología
Enzyme Structure and Function
article

Visual and Refractive Outcomes After Bilateral Implantation of a New Toric Intraocular Lens

article en

Abstract

Maya C Shammas,1 H John Shammas1,2 1The Department of Ophthalmology, The Shammas Eye Medical Center, Lynwood, CA, USA; 2The Department of Ophthalmology, University of Southern California, The Keck School of Medicine, Los Angeles, CA, USACorrespondence: Maya C Shammas, The Department of Ophthalmology, The Shammas Eye Medical Center, 3510 Martin Luther King Jr. Blvd, Lynwood, CA, 90262, USA, Tel +1 310 638 9391, Email [email protected]: To evaluate the clinical outcomes of a new FDA approved toric aspheric hydrophobic acrylic intraocular lens.Patients and Methods: This is a single surgeon, single-arm, on-label, non-randomized, prospective observational study. Thirty patients underwent bilateral cataract surgery (60 eyes) with placement of a Clareon™ Toric IOL in each eye. The Barrett Universal II formula and Barrett toric calculator were used to determine the IOL power and toric axis. Endpoints included binocular and monocular best corrected distance visual acuity (BCDVA), binocular and monocular best uncorrected distance visual acuity (UCDVA), binocular uncorrected intermediate visual acuity (UCIVA), manifest refraction and patient Satisfaction Survey (IOLSAT) results over a 3 month follow-up.Results: The postoperative mean LogMAR visual acuity for binocular BCDVA and UCDVA were each 0.01± 0.05. The monocular BCDVA and UCDVA were 0.04± 0.06 and 0.08± 0.08 respectively. The mean refractive cylinder improved from 1.87± 1.12D to 0.43± 0.25D with 78.3% within 0.50D. The mean refractive spherical equivalent (MRSE) was 0.008 ± 0.30 D (range − 0.75 to +0.63, 93.3% results within ± 0.5D). Patient surveys showed 96.7% gained distance spectacle independence and 96.7% would recommend this lens to friends or family members.Conclusion: The Clareon Monofocal Toric IOL is effective in astigmatism correction and significantly improved uncorrected distance visual acuity. High spectacle independence for distance vision and high overall satisfaction were achieved.Keywords: toric, intraocular lens, IOL, cataract, astigmatism

SHILAP Revista de lepidopterología
Partnerships for the goals
Openalex Percentile: Top 68%
Enzyme Structure and Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Visual and Refractive Outcomes After Bilateral Implantation of a New Toric Intraocular Lens · SHILAP Revista de lepidopterología (2024) | TGRS Research Map | TGRS